{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:54:22Z","timestamp":1789084462203,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01082-z","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:09:50Z","timestamp":1767690590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated in silico and in vitro evaluation of Genistein and Apigenin as dual inhibitors of PARP1 and ESR1 in breast cancer"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0633-6621","authenticated-orcid":false,"given":"Monica","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2026-7522","authenticated-orcid":false,"given":"Yahya S.","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4915-417X","authenticated-orcid":false,"given":"Ammar A. Razzak","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibghatullah Muhammad Ali","family":"Sangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2058-255X","authenticated-orcid":false,"given":"Sreeharsha","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0454-2471","authenticated-orcid":false,"given":"Santosh Prasad Chaudhary","family":"Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-5668","authenticated-orcid":false,"given":"Shankar","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"1082_CR1","unstructured":"WHO. Global cancer burden growing, amidst mounting need for services, WHO, 2024. https:\/\/www.who.int\/pitcairnislands\/news\/detail-global\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services?utm_source=chatgpt.com (accessed May 23, 2025)."},{"issue":"3","key":"1082_CR2","doi-asserted-by":"publisher","first-page":"s995","DOI":"10.5530\/ijper.58.3s.99","volume":"58","author":"S Sadik","year":"2024","unstructured":"Sadik S, Vasia AK, Maiti BA, Shivapooji, Jana S. Green synthesis of silver nano particles structural characterization and their antioxidant and anticancer potential using adenocarcinoma (A549) cell line. Indian J Pharm Educ Res. 2024;58(3):s995\u20131007. https:\/\/doi.org\/10.5530\/ijper.58.3s.99.","journal-title":"Indian J Pharm Educ Res"},{"issue":"1","key":"1082_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu JJ, Ding J. Natural products in cancer therapy: Past, present and future. Nat Prod Bioprospect. 2021;11(1):5\u201313. https:\/\/doi.org\/10.1007\/s13659-020-00293-7.","journal-title":"Nat Prod Bioprospect"},{"issue":"28","key":"1082_CR4","doi-asserted-by":"publisher","first-page":"31187","DOI":"10.1021\/acsomega.5c05895","volume":"10","author":"C Alvizo-Rodr\u00edguez","year":"2025","unstructured":"Alvizo-Rodr\u00edguez C, Carrasco-Carballo A, L\u00f3pez-V\u00e1zquez U, Hern\u00e1ndez-Montes G, Hern\u00e1ndez-Caballero ME. Transcriptome analysis of Triple-Negative HCC1937 and MDA-MB-231 breast cancer cells treated with Kalanchoe pinnata revealed the regulation of migration and invasion via the downregulation of the genes JAK2, ROCK1 and ROCK2. ACS Omega. 2025;10(28):31187\u2013200. https:\/\/doi.org\/10.1021\/acsomega.5c05895.","journal-title":"ACS Omega"},{"issue":"6","key":"1082_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25063254","volume":"25","author":"C Almeida-Ferreira","year":"2024","unstructured":"Almeida-Ferreira C, et al. Efficacy of cold atmospheric plasma vs. Chemotherapy in triple-negative breast cancer: a systematic review. Int J Mol Sci. 2024;25(6):1\u201328. https:\/\/doi.org\/10.3390\/ijms25063254.","journal-title":"Int J Mol Sci"},{"key":"1082_CR6","doi-asserted-by":"publisher","first-page":"115170","DOI":"10.1016\/j.biopha.2023.115170","volume":"165","author":"R Farghadani","year":"2023","unstructured":"Farghadani R, Naidu R. The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC). Biomed Pharmacother. 2023;165:115170. https:\/\/doi.org\/10.1016\/j.biopha.2023.115170.","journal-title":"Biomed Pharmacother"},{"key":"1082_CR7","doi-asserted-by":"publisher","unstructured":"Sharifi-Rad J, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021:1\u201336. https:\/\/doi.org\/10.1155\/2021\/3268136.","DOI":"10.1155\/2021\/3268136"},{"issue":"1","key":"1082_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/13880209.2025.2469607","volume":"63","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Ma B, Pei X, Wang W, Gong W. Mechanism of action of genistein on breast cancer and differential effects of different age stages. Pharm Biol. 2025;63(1):141\u201355. https:\/\/doi.org\/10.1080\/13880209.2025.2469607.","journal-title":"Pharm Biol"},{"key":"1082_CR9","doi-asserted-by":"publisher","unstructured":"Sohel M, et al. Genistein, a potential phytochemical against breast cancer treatment-insight into the molecular mechanisms. Processes 2022;10(2):1\u201322. https:\/\/doi.org\/10.3390\/pr10020415.","DOI":"10.3390\/pr10020415"},{"key":"1082_CR10","doi-asserted-by":"publisher","unstructured":"Ou M, et al. Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation. Front. Pharmacol. 2024;5(November):1\u201318. https:\/\/doi.org\/10.3389\/fphar.2024.1496664.","DOI":"10.3389\/fphar.2024.1496664"},{"key":"1082_CR11","doi-asserted-by":"crossref","unstructured":"Lee HH, Jung J, Moon A, Kang H, Cho H. Antitumor and Anti-Invasive E Ff Ect of apigenin on human breast carcinoma through suppression of IL-6 expression, 2019.","DOI":"10.3390\/ijms20133143"},{"issue":"7","key":"1082_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/jn\/130.7.1665","volume":"130","author":"RC Santell","year":"2000","unstructured":"Santell RC, Kieu N, Helferich WG. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr. 2000;130(7):1665\u20139. https:\/\/doi.org\/10.1093\/jn\/130.7.1665.","journal-title":"J Nutr"},{"issue":"1","key":"1082_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12609-025-00582-5","volume":"17","author":"A Ray","year":"2025","unstructured":"Ray A, Opyrchal M. Targeting PARP1: A promising approach for Next-Generation Poly (ADP-ribose) polymerase inhibitors. Curr Breast Cancer Rep. 2025;17(1):1\u201314. https:\/\/doi.org\/10.1007\/s12609-025-00582-5.","journal-title":"Curr Breast Cancer Rep"},{"key":"1082_CR14","doi-asserted-by":"publisher","first-page":"102651","DOI":"10.1016\/j.dnarep.2019.102651","volume":"81","author":"Y Wang","year":"2019","unstructured":"Wang Y, Luo W, Wang Y. PARP-1 and its associated nucleases in DNA damage response. DNA Repair (Amst). 2019;81:102651. https:\/\/doi.org\/10.1016\/j.dnarep.2019.102651.","journal-title":"DNA Repair (Amst)"},{"issue":"12","key":"1082_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0309797","volume":"19","author":"B Pandey","year":"2024","unstructured":"Pandey B, et al. LC-MS profiling and cytotoxic activity of angiopteris Helferiana against HepG2 cell line: molecular insight to investigate anticancer agent. PLoS ONE. 2024;19(12):1\u201324. https:\/\/doi.org\/10.1371\/journal.pone.0309797.","journal-title":"PLoS ONE"},{"issue":"1","key":"1082_CR16","doi-asserted-by":"publisher","first-page":"188830","DOI":"10.1016\/j.bbcan.2022.188830","volume":"1878","author":"A Grinshpun","year":"2023","unstructured":"Grinshpun A, Chen V, Sandusky ZM, Fanning SW, Jeselsohn R. ESR1 activating mutations: from structure to clinical application. Biochim Biophys Acta - Rev Cancer. 2023;1878(1):188830. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188830.","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"1082_CR17","doi-asserted-by":"publisher","unstructured":"Rahmani AH, et al. The potential role of apigenin in cancer prevention and treatment. Molecules. Sep. 2022;27:6051. https:\/\/doi.org\/10.3390\/molecules27186051.","DOI":"10.3390\/molecules27186051"},{"key":"1082_CR18","doi-asserted-by":"publisher","unstructured":"Tuli HS, et al. Molecular mechanisms of action of genistein in cancer: recent advances. Front. Pharmacol. 2019;10(December):1\u201316. https:\/\/doi.org\/10.3389\/fphar.2019.01336.","DOI":"10.3389\/fphar.2019.01336"},{"key":"1082_CR19","doi-asserted-by":"publisher","unstructured":"Pires DEV, Blundell TL, Ascher DB. PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. May 2015;58(9):4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","DOI":"10.1021\/acs.jmedchem.5b00104"},{"key":"1082_CR20","doi-asserted-by":"publisher","unstructured":"Safran M et al. GeneCards Version 3: the human gene integrator., Database (Oxford)., vol. 2010, pp. 1\u201316, 2010. https:\/\/doi.org\/10.1093\/database\/baq020","DOI":"10.1093\/database\/baq020"},{"issue":"1","key":"1082_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-024-10964-1","volume":"25","author":"KU Tribhuvan","year":"2024","unstructured":"Tribhuvan KU, et al. Identification, genomic localization, and functional validation of salt-stress-related LncRNAs in Indian mustard (Brassica juncea L). BMC Genomics. 2024;25(1):1\u201312. https:\/\/doi.org\/10.1186\/s12864-024-10964-1.","journal-title":"BMC Genomics"},{"key":"1082_CR22","doi-asserted-by":"publisher","unstructured":"Szklarczyk D, et al. Erratum: The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets (Nucleic Acids Research (2021) 49 (D605\u2013D612) 10.1093\/nar\/gkaa1074). Nucleic Acids Res. 2021;49(18):10800. https:\/\/doi.org\/10.1093\/nar\/gkab835.","DOI":"10.1093\/nar\/gkab835"},{"issue":"1","key":"1082_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):1\u201315. https:\/\/doi.org\/10.1186\/s13059-019-1758-4.","journal-title":"Genome Biol"},{"issue":"8","key":"1082_CR24","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Jung D, Yao R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"key":"1082_CR25","doi-asserted-by":"publisher","first-page":"100636","DOI":"10.1016\/j.prmcm.2025.100636","volume":"16","author":"S Thapa","year":"2025","unstructured":"Thapa S, Nath S, Manjunath K. LC-MS profiling and multi-target mechanistic insights of hibiscus rosa-sinensis in diabetes: network pharmacology, molecular docking, MD simulation, PCA, and in-vitro \u03b1 -amylase Inhibition. Pharmacol Res - Mod Chin Med. 2025;16:100636. https:\/\/doi.org\/10.1016\/j.prmcm.2025.100636.","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"1082_CR26","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"key":"1082_CR27","doi-asserted-by":"publisher","unstructured":"Tang D, et al. SRplot: a free online platform for data visualization and graphing. PLoS One 2023;18(11 October):1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0294236.","DOI":"10.1371\/journal.pone.0294236"},{"key":"1082_CR28","doi-asserted-by":"publisher","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u2013W514. https:\/\/doi.org\/10.1093\/NAR\/GKAA407.","DOI":"10.1093\/NAR\/GKAA407"},{"key":"1082_CR29","doi-asserted-by":"publisher","unstructured":"Li T, TIMER, et al. A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. Nov. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","DOI":"10.1158\/0008-5472.CAN-17-0307"},{"key":"1082_CR30","doi-asserted-by":"publisher","unstructured":"Velagapudi UK, et al. HHS public access. Design. 2020;5330\u201357. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01709.","DOI":"10.1021\/acs.jmedchem.8b01709"},{"key":"1082_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.72512","volume":"11","author":"DJ Hosfield","year":"2022","unstructured":"Hosfield DJ, et al. Stereospecific Lasofoxifene derivatives reveal the interplay between Estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife. 2022;11:1\u201327. https:\/\/doi.org\/10.7554\/eLife.72512.","journal-title":"Elife"},{"key":"1082_CR32","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/j.imu.2023.101213","volume":"38","author":"S Thapa","year":"2023","unstructured":"Thapa S, Nargund SL, Biradar MS, Banerjee J, Karati D. In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation. Inf Med Unlocked. 2023;38:101213. https:\/\/doi.org\/10.1016\/j.imu.2023.101213.","journal-title":"Inf Med Unlocked"},{"key":"1082_CR33","doi-asserted-by":"publisher","unstructured":"Thapa S, Nargund SL, Biradar MS. Molecular design and in-silico analysis of trisubstituted benzimidazole derivatives as Ftsz inhibitor. J Chem. 2023 Mar;2023(7):1\u20139. https:\/\/doi.org\/10.1155\/2023\/9307613.","DOI":"10.1155\/2023\/9307613"},{"key":"1082_CR34","doi-asserted-by":"publisher","first-page":"136304","DOI":"10.1016\/j.molstruc.2023.136304","volume":"1294","author":"SN Sriharsha","year":"2023","unstructured":"Sriharsha SN, et al. Novel \u03b2-L-1,3-thiazolidine pyrimidine nucleoside analogues: Design, synthesis, molecular docking, and anti-HIV activity. J Mol Struct. 2023;1294:136304. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136304.","journal-title":"J Mol Struct"},{"key":"1082_CR35","doi-asserted-by":"publisher","unstructured":"C P, et al. Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: a systems pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis. Bioinform Biol Insights. 2025;19:1-21. https:\/\/doi.org\/10.1177\/11779322251365019.","DOI":"10.1177\/11779322251365019"},{"key":"1082_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44371-025-00188-x","volume":"2","author":"S Prasad","year":"2025","unstructured":"Prasad S, Thapa S, Metri SM, Suresha M. Molecular docking, drug \u2013 likeness properties, and toxicity prediction of alkaloidal phytoconstituents of Piper longum against monoamine oxidase enzyme \u2013 A as an anti \u2013 depressive agent. Discov Chem. 2025;2:1\u201318. https:\/\/doi.org\/10.1007\/s44371-025-00188-x.","journal-title":"Discov Chem"},{"key":"1082_CR37","doi-asserted-by":"publisher","unstructured":"Kurmi SPC, Thapa S, Karati D. Molecular docking and pharmacokinetic evaluations of curcumin-based scaffolds as MDM2\u2013p53 inhibitors. Discov Chem. 2025;2(1):53. https:\/\/doi.org\/10.1007\/s44371-025-00128-9.","DOI":"10.1007\/s44371-025-00128-9"},{"key":"1082_CR38","doi-asserted-by":"publisher","unstructured":"Kiran S, et al. Integrated computational approach revealed the potential inhibitory effect of xanthone derivatives against Marburg virus nucleocapsid. VirusDisease. 2025;36(3):415\u2013427. https:\/\/doi.org\/10.1007\/s13337-025-00933-x.","DOI":"10.1007\/s13337-025-00933-x"},{"issue":"1","key":"1082_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-57124-9","volume":"14","author":"K Nyambo","year":"2024","unstructured":"Nyambo K, et al. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Sci Rep. 2024;14(1):1\u201322. https:\/\/doi.org\/10.1038\/s41598-024-57124-9.","journal-title":"Sci Rep"},{"key":"1082_CR40","doi-asserted-by":"publisher","first-page":"26631","DOI":"10.1038\/srep26631","volume":"6","author":"RS Nair","year":"2016","unstructured":"Nair RS, et al. Increased sensitivity of BRCA defective triple negative breast tumors to Plumbagin through induction of DNA double strand breaks (DSB). Sci Rep. 2016;6:26631. https:\/\/doi.org\/10.1038\/srep26631.","journal-title":"Sci Rep"},{"issue":"2","key":"1082_CR41","first-page":"1","volume":"18","author":"LF Abu-Marzoq","year":"2024","unstructured":"Abu-Marzoq LF, Ali E-MQA-BM, Aliwaini SH. The anticancer effects A new benzimidazole on HCC1937 breast cancer cell line. Onkol I Radioter. 2024;18(2):1\u20138.","journal-title":"Onkol I Radioter"},{"issue":"4","key":"1082_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15430\/jcp.2019.24.4.197","volume":"24","author":"GY Kim","year":"2019","unstructured":"Kim GY, et al. Genistein inhibits proliferation of BRCA1 mutated breast cancer cells: the GPR30-Akt axis as a potential target. J Cancer Prev. 2019;24(4):197\u2013207. https:\/\/doi.org\/10.15430\/jcp.2019.24.4.197.","journal-title":"J Cancer Prev"},{"issue":"2","key":"1082_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10549-015-3376-5","volume":"151","author":"M Kai","year":"2015","unstructured":"Kai M, et al. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin. Breast Cancer Res Treat. 2015;151(2):281\u201394. https:\/\/doi.org\/10.1007\/s10549-015-3376-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"1082_CR44","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1039\/d2md00148a","volume":"13","author":"D Zha","year":"2022","unstructured":"Zha D, et al. Synthesis and in vitro anticancer evaluation of novel flavonoid-based amide derivatives as regulators of the PI3K\/AKT signal pathway for TNBC treatment. RSC Med Chem. 2022;13(9):1082\u201399. https:\/\/doi.org\/10.1039\/d2md00148a.","journal-title":"RSC Med Chem"},{"issue":"1","key":"1082_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-023-00853-2","volume":"18","author":"L Li","year":"2023","unstructured":"Li L, et al. Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine. Chin Med (United Kingdom). 2023;18(1):1\u201319. https:\/\/doi.org\/10.1186\/s13020-023-00853-2.","journal-title":"Chin Med (United Kingdom)"},{"issue":"5","key":"1082_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph17050617","volume":"17","author":"R Arif","year":"2024","unstructured":"Arif R, Bukhari SA, Mustafa G, Ahmed S, Albeshr MF. Network Pharmacology and experimental validation to explore the potential mechanism of Nigella sativa for the treatment of breast cancer. Pharmaceuticals. 2024;17(5):1\u201323. https:\/\/doi.org\/10.3390\/ph17050617.","journal-title":"Pharmaceuticals"},{"key":"1082_CR47","doi-asserted-by":"publisher","unstructured":"N B. Network pharmacology-based investigation on the mechanism of tetrandrine against breast cancer. Phytomedicine Plus. 2023;3(1):100381. https:\/\/doi.org\/10.1016\/j.phyplu.2022.100381.","DOI":"10.1016\/j.phyplu.2022.100381"},{"issue":"3","key":"1082_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.32607\/20758251-2015-7-3-133-139","volume":"7","author":"AM Scherbakov","year":"2015","unstructured":"Scherbakov AM, Andreeva OE. Apigenin inhibits growth of breast cancer cells: the role of era and HER2\/neu. Acta Naturae. 2015;7(3):133\u20139. https:\/\/doi.org\/10.32607\/20758251-2015-7-3-133-139.","journal-title":"Acta Naturae"},{"issue":"7","key":"1082_CR49","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-07-2350","volume":"7","author":"X Long","year":"2008","unstructured":"Long X, Fan M, Bigsby RM, Nephew KP. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through Estrogen receptor-\u03b1-dependent and Estrogen receptor-\u03b1-independent mechanisms. Mol Cancer Ther. 2008;7(7):2096\u2013108. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-2350.","journal-title":"Mol Cancer Ther"},{"key":"1082_CR50","doi-asserted-by":"publisher","unstructured":"Ji X, et al. A mini-review of flavone isomers apigenin and genistein in prostate cancer treatment. Front Pharmacol. 2022;13:1\u20139. https:\/\/doi.org\/10.3389\/fphar.2022.851589.","DOI":"10.3389\/fphar.2022.851589"},{"issue":"1","key":"1082_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-11441-z","volume":"12","author":"AA Mahbub","year":"2022","unstructured":"Mahbub AA, Le Maitre CL, Cross NA, Jordan-Mahy N. The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines. Sci Rep. 2022;12(1):1\u201317. https:\/\/doi.org\/10.1038\/s41598-022-11441-z.","journal-title":"Sci Rep"},{"issue":"4","key":"1082_CR52","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.5114\/aoms.2018.78742","volume":"15","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Bao J, Yang J. Genistein-triggered anticancer activity against liver cancer cell line HepG2 involves ROS generation, mitochondrial apoptosis, G2\/M cell cycle arrest and Inhibition of cell migrationand Inhibition of cell migration. Arch Med Sci. 2019;15(4):1001\u20139. https:\/\/doi.org\/10.5114\/aoms.2018.78742.","journal-title":"Arch Med Sci"},{"issue":"2","key":"1082_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0031964","volume":"7","author":"P Singh","year":"2012","unstructured":"Singh P, Mishra SK, Noel S, Sharma S, Rath SK. Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS ONE. 2012;7(2):1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0031964.","journal-title":"PLoS ONE"},{"issue":"1","key":"1082_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40203-023-00170-4","volume":"11","author":"N Divya Rajaselvi","year":"2023","unstructured":"Divya Rajaselvi N, Jida MD, Nair DB, Sujith S, Beegum N, Nisha AR. Toxicity prediction and analysis of flavonoid apigenin as a histone deacetylase inhibitor: an in-silico approach. Silico Pharmacol. 2023;11(1):1\u201312. https:\/\/doi.org\/10.1007\/s40203-023-00170-4.","journal-title":"Silico Pharmacol"},{"key":"1082_CR55","doi-asserted-by":"publisher","unstructured":"Wang M, Firrman J, Liu LS, Yam K. A review on flavonoid apigenin: dietary intake, ADME, antimicrobial effects, and interactions with human gut microbiota. Biomed Res Int. 2019;2019:1\u201318. https:\/\/doi.org\/10.1155\/2019\/7010467.","DOI":"10.1155\/2019\/7010467"},{"key":"1082_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.seminoncol.2023.08.001","volume":"51","author":"PB Kanev","year":"2024","unstructured":"Kanev PB, Atemin A, Stoynov S, Aleksandrov R. PARP1 roles in DNA repair and DNA replication: the basi(c)s of PARP inhibitor efficacy and resistance. Semin Oncol. 2024;51:1\u20132. https:\/\/doi.org\/10.1053\/j.seminoncol.2023.08.001.","journal-title":"Semin Oncol"},{"key":"1082_CR57","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0301-472X(03)00083-3","volume":"31","author":"VJ Bouchard","year":"2003","unstructured":"Bouchard VJ, Rouleau M, Poirier GG. PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol. 2003;31:446\u201354. https:\/\/doi.org\/10.1016\/S0301-472X(03)00083-3.","journal-title":"Exp Hematol"},{"issue":"6","key":"1082_CR58","doi-asserted-by":"publisher","first-page":"109995","DOI":"10.1016\/j.isci.2024.109995","volume":"27","author":"CC Oturkar","year":"2024","unstructured":"Oturkar CC, et al. ESR1 and p53 interactome alteration defines mechanisms of Tamoxifen response in luminal breast cancer. iScience. 2024;27(6):109995. https:\/\/doi.org\/10.1016\/j.isci.2024.109995.","journal-title":"iScience"},{"issue":"1","key":"1082_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-021-01462-3","volume":"23","author":"JO Brett","year":"2021","unstructured":"Brett JO, Spring LM, Bardia A, Wander SA. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Res. 2021;23(1):1\u201315. https:\/\/doi.org\/10.1186\/s13058-021-01462-3.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1082_CR60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2225-4110(16)30082-7","volume":"2","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kim H, Song YS. Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med. 2012;2(2):96\u2013104. https:\/\/doi.org\/10.1016\/S2225-4110(16)30082-7.","journal-title":"J Tradit Complement Med"},{"key":"1082_CR61","doi-asserted-by":"publisher","unstructured":"Kumi-Diaka J, Sanderson NA, Hall A. The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines DU145 and LNCaP. Biol Cell. 2000;92(8\u20139):595\u2013604. https:\/\/doi.org\/10.1016\/S0248-4900(00)01109-6.","DOI":"10.1016\/S0248-4900(00)01109-6"},{"issue":"1","key":"1082_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-01888-x","volume":"21","author":"Z Javed","year":"2021","unstructured":"Javed Z, et al. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment. Cancer Cell Int. 2021;21(1):1\u201311. https:\/\/doi.org\/10.1186\/s12935-021-01888-x.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"1082_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25105569","volume":"25","author":"V Naponelli","year":"2024","unstructured":"Naponelli V, Rocchetti MT, Mangieri D. Apigenin: molecular mechanisms and therapeutic potential against cancer spreading. Int J Mol Sci. 2024;25(10):1\u201333. https:\/\/doi.org\/10.3390\/ijms25105569.","journal-title":"Int J Mol Sci"},{"key":"1082_CR64","doi-asserted-by":"publisher","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355(6330):1152\u20131158. https:\/\/doi.org\/10.1126\/science.aam7344.","DOI":"10.1126\/science.aam7344"},{"issue":"11","key":"1082_CR65","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390. https:\/\/doi.org\/10.1038\/nchembio.118.","journal-title":"Nat Chem Biol"},{"issue":"9","key":"1082_CR66","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-09-2937","volume":"16","author":"Y Li","year":"2010","unstructured":"Li Y, et al. Sulforaphane, a dietary component of broccoli\/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010;16(9):2580\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2937.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1082_CR67","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.3390\/ijms10115002","volume":"10","author":"T Walle","year":"2009","unstructured":"Walle T. Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. Int J Mol Sci. 2009;10(11):5002\u201319. https:\/\/doi.org\/10.3390\/ijms10115002.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1082_CR68","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/or.2015.4022","volume":"34","author":"X Liu","year":"2015","unstructured":"Liu X, Li L, Lv L, Chen D, Shen L, Xie Z. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt\/\u03b2-catenin signaling pathway. Oncol Rep. 2015;34(2):1035\u201341. https:\/\/doi.org\/10.3892\/or.2015.4022.","journal-title":"Oncol Rep"},{"issue":"8","key":"1082_CR69","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s004320050012","volume":"126","author":"H Nakagawa","year":"2000","unstructured":"Nakagawa H, et al. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. J Cancer Res Clin Oncol. 2000;126(8):448\u201354. https:\/\/doi.org\/10.1007\/s004320050012.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1082_CR70","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1080\/10942912.2023.2281257","volume":"26","author":"H Naeem","year":"2023","unstructured":"Naeem H, et al. Anticancer perspectives of genistein: a comprehensive review. Int J Food Prop. 2023;26(2):3305\u201341. https:\/\/doi.org\/10.1080\/10942912.2023.2281257.","journal-title":"Int J Food Prop"},{"key":"1082_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1512745","volume":"2017","author":"R Souza","year":"2017","unstructured":"Souza R P, et al. Oxidative stress triggered by apigenin induces apoptosis in a comprehensive panel of human cervical Cancer-Derived cell lines. Oxid Med Cell Longev. 2017;2017:1\u201318. https:\/\/doi.org\/10.1155\/2017\/1512745.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"1082_CR72","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.biochi.2013.02.010","volume":"95","author":"D Choudhury","year":"2013","unstructured":"Choudhury D, Ganguli A, Dastidar DG, Acharya BR, Das A, Chakrabarti G. Apigenin shows synergistic anticancer activity with Curcumin by binding at different sites of tubulin. Biochimie. 2013;95(6):1297\u2013309. https:\/\/doi.org\/10.1016\/j.biochi.2013.02.010.","journal-title":"Biochimie"},{"key":"1082_CR73","doi-asserted-by":"publisher","unstructured":"Kaewmanee M, Limpaiboon T, Ngernyuang N. Apigenin induces apoptosis and inhibits migration in human cholangiocarcinoma cells. Toxics. 2025;13(2):1\u201311. https:\/\/doi.org\/10.3390\/toxics13020112.","DOI":"10.3390\/toxics13020112"},{"issue":"20","key":"1082_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27207042","volume":"27","author":"JP Rend\u00f3n","year":"2022","unstructured":"Rend\u00f3n JP, et al. Evaluation of the effects of genistein in vitro as a chemopreventive agent for colorectal Cancer\u2014Strategy to improve its efficiency when administered orally. Molecules. 2022;27(20):1\u201320. https:\/\/doi.org\/10.3390\/molecules27207042.","journal-title":"Molecules"},{"issue":"10","key":"1082_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25105556","volume":"25","author":"EK Konstantinou","year":"2024","unstructured":"Konstantinou EK, Gioxari A, Dimitriou M, Panoutsopoulos GI, Panagiotopoulos AA. Molecular pathways of genistein activity in breast cancer cells. Int J Mol Sci. 2024;25(10):1\u201322. https:\/\/doi.org\/10.3390\/ijms25105556.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1082_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14071824","volume":"14","author":"YH Chen","year":"2022","unstructured":"Chen YH, Wu JX, Yang SF, Yang CK, Chen TH, Hsiao YH. Anticancer effects and molecular mechanisms of apigenin in cervical cancer cells. Cancers (Basel). 2022;14(7):1\u201320. https:\/\/doi.org\/10.3390\/cancers14071824.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1082_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25010251","volume":"25","author":"L Fossatelli","year":"2024","unstructured":"Fossatelli L, Maroccia Z, Fiorentini C, Bonucci M. Resources for human health from the plant kingdom: the potential role of the flavonoid apigenin in cancer counteraction. Int J Mol Sci. 2024;25(1):1\u201318. https:\/\/doi.org\/10.3390\/ijms25010251.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1082_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-017-0179-x","volume":"7","author":"X Yan","year":"2017","unstructured":"Yan X, Qi M, Li P, Zhan Y, Shao H. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 2017;7(1):1\u201316. https:\/\/doi.org\/10.1186\/s13578-017-0179-x.","journal-title":"Cell Biosci"},{"key":"1082_CR79","doi-asserted-by":"publisher","unstructured":"Tassone P, et al. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer. 2003;88(8):1285\u20131291. https:\/\/doi.org\/10.1038\/sj.bjc.6600859.","DOI":"10.1038\/sj.bjc.6600859"},{"issue":"4","key":"1082_CR80","first-page":"155","volume":"13","author":"AA Alnaim","year":"2024","unstructured":"Alnaim AA, et al. Synthesis and characterization of silver nano particles of Kaempferol and their application as antibacterial and against prostate cells (Pc-3). Front Heal Inf. 2024;13(4):155\u201366.","journal-title":"Front Heal Inf"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01082-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:32:02Z","timestamp":1767882722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01082-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}